In this podcast, 3 members of the Cancer.Net Editorial Board discuss new research presented at the 2023 ASCO Annual Meeting in non-small cell lung cancer, small cell lung cancer, and mesothelioma. Read More >>
immunotherapy
September 28, 2023 · Anna Schardt Baker
September 12, 2023 · Anna Schardt Baker
In this podcast, 2 Cancer.Net Associate Editors discuss new research presented at the 2023 ASCO Annual Meeting about preventing melanoma recurrence and reducing cancer disparities. Read More >>
July 27, 2023 · Brielle Gregory Collins, ASCO staff
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2023 ASCO Annual Meeting in breast cancer, lymphoma, multiple myeloma, brain tumors, and von Hippel-Lindau syndrome. Read More >>
June 22, 2023 · Bryant Wieneke
In this post, melanoma survivor Bryant Wieneke reflects on what it was like being diagnosed with advanced disease, how he felt more vulnerable after being diagnosed with a second cancer years later, and how he is supporting his mental health. Read More >>
June 5, 2023 · ASCO Staff
The ASCO Annual Meeting is being held June 2 to 6. Research highlights from the day include using trastuzumab deruxtecan to treat HER2-expressing tumors and using CAR T-cell therapy to slow or stop multiple myeloma. Read More >>